PROCHLORPERAZINE EDISYLATE
Active substance: prochlorperazine edisylate
INJECTION · PROCHLORPERAZINE EDISYLATE 5 mg/mL
United StatesActive
Marketing holder: Sagent Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PROCHLORPERAZINE EDISYLATE · 5 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-0178-7840-8503-3e751e61ac40,01a1208e-4037-7d70-ad08-d92a6c4b3414,01a1208f-d8c9-7745-ae2e-cdba87a80853,01a12090-9555-7809-b65b-ffc8586f8c26,01a12090-ac93-7c70-9028-3b587ab411d9;count=18 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 25021-790
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS
Sources
- product · openFDA NDC · 25021-790 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 25021-790 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 25021-790 · Verified 2026-10-09 · open in source